Clinical Trial: Antiphospholipid Syndrome Collaborative Registry (APSCORE)

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Antiphospholipid Syndrome Collaborative Registry (APSCORE)

Brief Summary:

Antiphospholipid Syndrome (APS) is an autoimmune disorder in which the body recognizes certain normal components of blood and/or cell membranes as foreign substances and produces antibodies against them. Patients with these antibodies may experience miscarriages and blood clotting disorders, including heart attacks and strokes. APS may occur in people with systemic lupus erythematosus and other autoimmune diseases, or in otherwise healthy individuals.

The Antiphospholipid Syndrome Collaborative Registry (APSCORE) is a national registry and tissue repository for patients with APS. This registry will collect clinical information and blood samples from people with APS.